Ikarian Capital
Overview
At Ikarian Capital, we leverage our medical background to invest both long and short in biotechnology and pharmaceuticals, industries that focus on improving health and the quality of life. Our disciplined research and risk processes reflect the importance we place on long-term capital preservation. We are committed to building an enduring business with strong values and high ethical standards.
Investment Focus
- Innovative drug discovery and development companies
- Strong business fundamentals
- Early to late-stage clinical trials
Portfolio Companies
Reach Ikarian Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Ikarian Capital
What sectors does Ikarian Capital invest in?
Ikarian Capital invests in Pharmaceuticals and Biotechnology, and is based in Dallas, Texas, United States. Ikarian Capital is listed as a private investment firm in the ConnectSafely investor database.
What stage does Ikarian Capital invest at?
Ikarian Capital backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Ikarian Capital invest in?
Ikarian Capital invests across United States.
What companies has Ikarian Capital invested in?
Ikarian Capital's portfolio includes Solid Biosciences, BioAtla, Renovacor and Forte Biosciences.
How do I contact Ikarian Capital?
Ikarian Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
